What do you predict Iovance Biotherapeutics stock price to be by the end of this week?

Iovance Biotherapeutics (NASDAQ: IOVA) is likely to experience a fluctuating upward trend in its stock price by the end of this week, with a forecasted mean price of $3.08 on July 23, 2025. Here's a detailed analysis: 1. **Current Price Trend**: IOVA's stock price has seen a significant surge, with a 23.5% intraday increase on July 23, 2025, reaching $3.075. 2. **Forecast Price**: The forecast for IOVA's stock price for the next few days shows a slight dip, with prices ranging from $3.01 to $3.16 between July 25 and July 28, followed by a slight increase to $3.16 by July 30. 3. **Market Sentiment**: The overall market sentiment for IOVA is positive, with recent developments such as FDA approval of Amtagvi and the appointment of Corleen Roche as CEO contributing to increased investor confidence. 4. **Challenges and Risks**: However, there are also concerns regarding slower-than-anticipated expansion of authorized treatment centers and potential challenges in maintaining revenue momentum. These factors could lead to some volatility in the stock price. 5. **Potential for Further Increase**: The potential for more robust pricing and stock stability overshadows the apparent short-term financial hurdles, suggesting that IOVA's stock could continue to rise if the company successfully executes its growth strategies. In summary, while there may be some fluctuations due to market dynamics and company-specific factors, the forecast suggests that IOVA's stock price is likely to end the week around $3.08, with a slight upward bias due to positive market sentiment and potential for growth.